負ののれん発生益、Reversal Of Reserve For Reduction Entry2RE、債権売却損他2件
- 【期間】
| 年度 | 負ののれん発生益 | Reversal Of Reserve For Reduction Entry2RE | 債権売却損 | 非支配株主への配当金の支払額 | 研究開発費 - ＦＴ |
|---|
| 2008/03 | - | | - | | 280百万 | | - | | - | |
| 2009/03 | - | | - | | 177百万 | -36.8% | - | | - | |
| 2010/03 | -24.7億 | | - | | 57百万 | -67.8% | - | | - | |
| 2012/03 | - | | - | | 1百万 | -98.2% | - | | - | |
| 2013/03 | - | | - | | 12百万 | 大幅増 | - | | - | |
| 2015/03 | -1.81億 | 赤縮 | - | | - | | -5百万 | | - | |
| 2016/03 | - | | - | | - | | -96百万 | 赤拡 | - | |
| 2017/03 | - | | - | | - | | -3百万 | 赤縮 | - | |
| 2019/03 | - | | - | | - | | - | | 12.6億 | |
| 2020/03 | - | | - | | - | | - | | 11.7億 | -7.4% |
| 2021/03 | - | | - | | - | | - | | 11.9億 | +1.6% |
| 2022/03 | - | | - | | - | | - | | 10億 | -15.5% |
| 2023/03 | - | | - | | - | | - | | 7.24億 | -27.7% |
| 2024/03 | - | | - | | - | | - | | 5.54億 | -23.5% |
